MedPath

Effect of routine treatment with and without intravenous immunoglobulin (IVIG) on fertility induction in patients with repeated unexplained in vitro fertilization failure

Phase 2
Conditions
Infertility.
Female infertility
Registration Number
IRCT20120215009014N217
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
42
Inclusion Criteria

Age of 20 to 35 years
Repeated unexplained in vitro fertilization failure

Exclusion Criteria

Anatomical abnormalities of the uterus
Endocrine disorder
Genetic disorder
Infectious diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath